Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-000608

CHIEF ACCOUNTING OFFICER sold 16,670 shares at $19.17 ($319,564)

  • CHIEF ACCOUNTING OFFICER acquired 16,670 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-01-02 Option exercise 10b5-1 +16,670 $13.88 $231,380 33,675 D: show line 1 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-01-02 Sale 10b5-1 −16,670 $19.17 $319,564 17,005 D: show line 2 in the form
Open-market sales · 16,670 sh · avg $19.17 · $319,564

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-01-02 Option exercise · Share Option 10b5-1 −16,670 4,014 D: show line 3 in the form
Loading xslF345X05/form4-01042024_040110.xml…